Today: 19 April 2026
Browse Category

LSE:SGRO 9 March 2026

UK stock market today: FTSE 100 pares early slump as oil shock hits London shares

UK stock market today: FTSE 100 pares early slump as oil shock hits London shares

FTSE 100 closed down 0.3% and FTSE 250 fell 1.6% after Brent crude surged over 25% to $119.50 a barrel amid the U.S.-Iran war. UK gilt yields jumped as traders shifted bets toward a possible Bank of England rate hike. Sterling weakened, while energy stocks like Shell and BP rose. Homebuilders and property shares led declines, with Persimmon down 5.5%.

Stock Market Today

  • Q4 Earnings, US-Iran Tensions and Oil Prices Set Indian Markets' Course Next Week
    April 19, 2026, 1:05 AM EDT. Indian stock markets posted modest weekly gains led by the Sensex and Nifty 50, buoyed by broad buying interest. Looking ahead, key triggers include the Q4 2026 earnings season with major firms like HDFC Bank and Infosys announcing results. The outcome could steer sector-specific moves. Renewed tension in the US-Iran peace talks and Iran's reversal on reopening the Strait of Hormuz heighten geopolitical risks, influencing risk sentiment and crude prices. A tentative US-Iran ceasefire had earlier eased energy supply fears, causing oil prices to tumble and supporting equities globally. Market watchers expect continued volatility driven by news flow and crude price fluctuations, impacting capital flows and investor confidence. Stability in these areas is crucial for sustaining the current positive momentum.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 19.04.2026

19 April 2026
LIVEMarkets rolling coverageStarted: April 19, 2026, 12:00 AM EDTUpdated: April 19, 2026, 1:05 AM EDT Q4 Earnings, US-Iran Tensions and Oil Prices Set Indian Markets' Course Next Week April 19, 2026, 1:05 AM EDT. **Indian stock markets** posted modest weekly gains led by the Sensex and Nifty 50, buoyed by broad buying interest. Looking ahead, key triggers include the **Q4 2026 earnings season** with major firms like HDFC Bank and Infosys announcing results. The outcome could steer sector-specific moves. Renewed tension in the **US-Iran peace talks** and Iran's reversal on reopening the Strait of Hormuz heighten geopolitical risks, influencing risk
Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Go toTop